Exact Mass: 1619.7103326

Exact Mass Matches: 1619.7103326

Found 8 metabolites which its exact mass value is equals to given mass value 1619.7103326, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Daptomycin

C72H101N17O26 (1619.7103326)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D01080 Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms. Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.

Cubicin

3-({3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl}-C-hydroxycarbonimidoyl)-3-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1H-indol-3-yl)propylidene}amino)-3-(C-hydroxycarbonimidoyl)propylidene]amino}propanoate

C72H101N17O26 (1619.7103326)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms. Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.

Cubicin

Daptomycin

C72H101N17O26 (1619.7103326)

A polypeptide comprising N-decanoyltryptophan, asparagine, aspartic acid, threonine, glycine, ornithine, aspartic acid, D-alanine, aspartic acid, glycine, D-serine, threo-3-methylglutamic acid and 3-anthraniloylalanine (also known as kynurinine) coupled in sequence and lactonised by condensation of the carboxylic acid group of the 3-anthraniloylalanine with the alcohol group of the threonine residue. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Same as: D01080 Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms. Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.

decanoyl-Trp-D-Asn-Asp-Thr(1)-Gly-D-Orn-Asp-Ala-Asp-Gly-D-Ser-Glu(3S-Me)-Asp(Ph(2-NH2))-(1)

C72H101N17O26 (1619.7103326)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use

(3s)-3-{[(3s,6s,9r,15s,18r,21s,24s,30s,31r)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2r)-1-carboxypropan-2-yl]-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

(3s)-3-{[(3s,6s,9r,15s,18r,21s,24s,30s,31r)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2r)-1-carboxypropan-2-yl]-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[(2r)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

C72H101N17O26 (1619.7103326)

(3s)-3-{[(3s,6s,9r,15s,18r,21s,24s)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

(3s)-3-{[(3s,6s,9r,15s,18r,21s,24s)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

C72H101N17O26 (1619.7103326)

(3s)-3-{[(3s,6s,9r,15s,18r,21s,24s,30s,31r)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2r)-1-carboxypropan-2-yl]-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

(3s)-3-{[(3s,6s,9r,15s,18r,21s,24s,30s,31r)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2r)-1-carboxypropan-2-yl]-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[(2s)-1-hydroxy-2-{[(2s)-1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

C72H101N17O26 (1619.7103326)

3-{[(3r,6r,9s,21r)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene}amino)-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

3-{[(3r,6r,9s,21r)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-5,8,11,14,17,20,23,26,29-nonahydroxy-9-(hydroxymethyl)-18,31-dimethyl-2-oxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriaconta-4,7,10,13,16,19,22,25,28-nonaen-30-yl]-c-hydroxycarbonimidoyl}-3-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxydecylidene)amino]-3-(1h-indol-3-yl)propylidene}amino)-3-(c-hydroxycarbonimidoyl)propylidene]amino}propanoic acid

C72H101N17O26 (1619.7103326)